What Does It Take to Transform Real‐World Data Into Real‐World Evidence?
- 26 June 2019
- journal article
- editorial
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 106 (1), 10-18
- https://doi.org/10.1002/cpt.1486
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- A Structured Preapproval and Postapproval Comparative Study Design Framework to Generate Valid and Transparent Real‐World Evidence for Regulatory DecisionsClinical Pharmacology & Therapeutics, 2019
- Barriers and Opportunities for Use of Patient Registries in Medicines RegulationClinical Pharmacology & Therapeutics, 2019
- Real‐World Data for Regulatory Decision Making: Challenges and Possible Solutions for EuropeClinical Pharmacology & Therapeutics, 2019
- Real‐World Data, Advanced Analytics, and the Evolution of Postmarket Drug Safety SurveillanceClinical Pharmacology & Therapeutics, 2019
- Real‐World Evidence of Treatment Effects: The Useful and the MisleadingClinical Pharmacology & Therapeutics, 2019
- Advances in the Use of Real‐World Evidence for Medical Devices: An Update From the National Evaluation System for Health TechnologyClinical Pharmacology & Therapeutics, 2019
- The US Food and Drug Administration's Real‐World Evidence Framework: A Commitment for Engagement and Transparency on Real‐World EvidenceClinical Pharmacology & Therapeutics, 2019
- Wearable Devices in Clinical Trials: Hype and HypothesisClinical Pharmacology & Therapeutics, 2018
- Harnessing the Power of Real-World Evidence (RWE): A Checklist to Ensure Regulatory-Grade Data QualityClinical Pharmacology & Therapeutics, 2018
- The ADAPTABLE Trial and PCORnet: Shining Light on a New Research ParadigmAnnals of Internal Medicine, 2015